DK1071779T3 - Patched-2-protein fra hvirveldyr - Google Patents

Patched-2-protein fra hvirveldyr

Info

Publication number
DK1071779T3
DK1071779T3 DK99945688T DK99945688T DK1071779T3 DK 1071779 T3 DK1071779 T3 DK 1071779T3 DK 99945688 T DK99945688 T DK 99945688T DK 99945688 T DK99945688 T DK 99945688T DK 1071779 T3 DK1071779 T3 DK 1071779T3
Authority
DK
Denmark
Prior art keywords
patched
vertebrates
protein
immunoadhesins
ests
Prior art date
Application number
DK99945688T
Other languages
Danish (da)
English (en)
Inventor
Frederic J Desauvage
David A Carpenter
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22032676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1071779(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1071779T3 publication Critical patent/DK1071779T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
DK99945688T 1998-04-15 1999-04-02 Patched-2-protein fra hvirveldyr DK1071779T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/060,939 US6709838B1 (en) 1998-04-15 1998-04-15 Nucleic acid encoding patched-2
PCT/US1999/007417 WO1999053058A1 (en) 1998-04-15 1999-04-02 Vertebrate patched-2 protein

Publications (1)

Publication Number Publication Date
DK1071779T3 true DK1071779T3 (da) 2009-02-16

Family

ID=22032676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99945688T DK1071779T3 (da) 1998-04-15 1999-04-02 Patched-2-protein fra hvirveldyr

Country Status (13)

Country Link
US (1) US6709838B1 (ja)
EP (1) EP1071779B1 (ja)
JP (2) JP4693237B2 (ja)
AT (1) ATE410513T1 (ja)
AU (1) AU765918B2 (ja)
CA (1) CA2323572C (ja)
CY (1) CY1108619T1 (ja)
DE (1) DE69939694D1 (ja)
DK (1) DK1071779T3 (ja)
ES (1) ES2316192T3 (ja)
IL (3) IL138585A0 (ja)
PT (1) PT1071779E (ja)
WO (1) WO1999053058A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999029854A1 (en) * 1997-12-08 1999-06-17 Ontogeny, Inc. Human patched genes and proteins, and uses related thereto
SE9803393D0 (sv) * 1998-10-06 1998-10-06 Karolinska Innovations Ab A novel component in the hedgehog signalling pathway
GB9908798D0 (en) * 1999-04-16 1999-06-09 Pharmacia & Upjohn Spa Human homologues of fused gene
AU2429201A (en) * 1999-12-10 2001-06-18 General Hospital Corporation, The Methods to stimulate insulin production by pancreatic beta-cells
SE0000345D0 (sv) * 2000-02-03 2000-02-03 Karolinska Innovations Ab New matter
EP1229046A3 (en) * 2001-01-30 2004-02-25 Aeomica, Inc. Human testis expressed patched like protein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
AU704178B2 (en) 1993-12-30 1999-04-15 Imperial Cancer Research Technology Ltd Vertebrate embryonic pattern-inducing hedgehog-like proteins
US6027882A (en) 1994-10-07 2000-02-22 The Regents Of The University Of California Patched genes and their use for diagnostics
EP0804548B1 (en) 1994-10-07 2005-07-13 The Board Of Trustees Of The Leland Stanford Junior University Patched genes and their use
US6051400A (en) 1997-05-23 2000-04-18 Smithkline Beecham Plc Patched-2 polypeptides and polynucleotides
WO1999029854A1 (en) 1997-12-08 1999-06-17 Ontogeny, Inc. Human patched genes and proteins, and uses related thereto
US6022708A (en) 1998-02-26 2000-02-08 Genentech, Inc. Fused
SE9803393D0 (sv) * 1998-10-06 1998-10-06 Karolinska Innovations Ab A novel component in the hedgehog signalling pathway

Also Published As

Publication number Publication date
IL138585A (en) 2010-11-30
CY1108619T1 (el) 2014-04-09
IL205793A (en) 2015-01-29
ATE410513T1 (de) 2008-10-15
ES2316192T3 (es) 2009-04-01
WO1999053058A1 (en) 1999-10-21
PT1071779E (pt) 2009-01-13
EP1071779A1 (en) 2001-01-31
US6709838B1 (en) 2004-03-23
EP1071779B1 (en) 2008-10-08
JP4693237B2 (ja) 2011-06-01
IL138585A0 (en) 2001-10-31
JP2002511263A (ja) 2002-04-16
JP2010046077A (ja) 2010-03-04
AU5265799A (en) 1999-11-01
DE69939694D1 (de) 2008-11-20
CA2323572A1 (en) 1999-10-21
CA2323572C (en) 2011-10-18
AU765918B2 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
ZA991525B (en) Vertebrate fused.
ATE371727T1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
ATE319818T1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
CA2174529A1 (en) Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof
CY1108619T1 (el) Πρωτεϊνη σπονδυλωτων patched-2
ATE450603T1 (de) Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren
DK1064376T3 (da) GFR-alpha3 og dets anvendelser
DK0804558T3 (da) Tripeptidylaminopeptidase
WO1999027098A3 (en) A-33 related antigens and their pharmacological uses
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
DE60025704D1 (de) Das goodpasture-antigen bindende protein
ES2152313T3 (es) Gen grb-3-3, sus variantes y sus utilizaciones.
DE69417223D1 (de) Ein menschlicher t-zell rezeptor der protein g-gekoppelte rezeptor familie
WO2000021986A3 (en) Matrix-remodeling genes
WO2002102847A1 (fr) Nouveau ligand et son adn
WO2001042285A3 (en) Extracellular matrix and cell adhesion proteins as well as genes encoding them
EP1140968A4 (en) HUMAN MELANOCORTIN-1 RECEPTOR PROTEIN DNA-MOLECULE-ENCODING SPLICE VERSIONS
WO2000065055A3 (en) Human transporter proteins
WO2000040607A3 (en) Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
WO2003087331A3 (en) Polyvalent cation-sensing receptor in atlantic salmon
KR920012433A (ko) Txa₂수용체 및 그것을 코딩하는 유전자
WO2000065025A3 (en) Dna molecules encoding human endothelin converting enzyme 3
CO5400145A1 (es) Proteina asociada con enfermedad
TW200702337A (en) Coronavirus S peptides
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.